Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)TB006 for Autism Spectrum Disorder
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Rossignol Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT06500637
- Locations
- 🇺🇸
Rossignol Medical Center, Aliso Viejo, California, United States
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
Phase 2
Completed
- Conditions
- Autism Spectrum Disorder
- Interventions
- Other: PlaceboDrug: Wide-spectrum nutritional supplement
- First Posted Date
- 2019-02-08
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Rossignol Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT03835117
- Locations
- 🇺🇸
Southwestern Research & Resource Center, Phoenix, Arizona, United States
News
No news found